Barclays’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $9.16M | Buy |
|
|||||
|
2025
Q2 | $4.79M | Sell |
|
|||||
|
2025
Q1 | $7.27M | Sell |
|
|||||
|
2024
Q4 | $13.3M | Sell |
|
|||||
|
2024
Q3 | $14M | Sell |
|
|||||
|
2024
Q2 | $12.9M | Buy |
|
|||||
|
2024
Q1 | $13.8M | Sell |
|
|||||
|
2023
Q4 | $20M | Buy |
|
|||||
|
2023
Q3 | $16.2M | Buy |
|
|||||
|
2023
Q2 | $16.7M | Buy |
|
|||||
|
2023
Q1 | $11.2M | Sell |
|
|||||
|
2022
Q4 | $27.9M | Buy |
|
|||||
|
2022
Q3 | $22.6M | Buy |
|
|||||
|
2022
Q2 | $11.5M | Sell |
|
|||||
|
2022
Q1 | $15.7M | Sell |
|
|||||
|
2021
Q4 | $27.8M | Sell |
|
|||||
|
2021
Q3 | $34.1M | Buy |
|
|||||
|
2021
Q2 | $21.1M | Buy |
|
|||||
|
2021
Q1 | $18.5M | Buy |
|
|||||
|
2020
Q4 | $12.2M | Sell |
|
|||||
|
2020
Q3 | $10.8M | Buy |
|
|||||
|
2020
Q2 | $9.27M | Sell |
|
|||||
|
2020
Q1 | $9.43M | Buy |
|
|||||
|
2019
Q4 | $9.82M | Sell |
|
|||||
|
2019
Q3 | $11.6M | Buy |
|
|||||
|
2019
Q2 | $9.75M | Buy |
|
|||||
|
2019
Q1 | $1.43M | Sell |
|
|||||
|
2018
Q4 | $10.8M | Buy |
|
|||||
|
2018
Q3 | $2.21M | Buy |
|
|||||
|
2018
Q2 | $1.23M | Sell |
|
|||||
|
2018
Q1 | $1.37M | Sell |
|
|||||
|
2017
Q4 | $1.8M | Buy |
|
|||||
|
2017
Q3 | $307K | Sell |
|
|||||
|
2017
Q2 | $972K | Buy |
|
|||||
|
2017
Q1 | $846K | Buy |
|
|||||
|
2016
Q4 | $168K | Buy |
|
|||||
|
2016
Q3 | $91K | Sell |
|
|||||
|
2016
Q2 | $149K | Buy |
|
|||||
|
2016
Q1 | $91K | Buy |
|
|||||
|
2015
Q4 | $85K | Buy |
|
|||||
|
2015
Q3 | $77K | Sell |
|
|||||
|
2015
Q2 | $103K | Sell |
|
|||||
|
2015
Q1 | $551K | Buy |
|
|||||
|
2014
Q4 | $435K | Sell |
|
|||||
|
2014
Q3 | $516K | Sell |
|
|||||
|
2014
Q2 | $684K | Sell |
|
|||||
|
2014
Q1 | $1.36M | Buy |
|
|||||
|
2013
Q4 | $1.06M | Buy |
|
|||||
|
2013
Q3 | $547K | Buy |
|
|||||
|
2013
Q2 | $330K | Buy |
|